185 related articles for article (PubMed ID: 24715127)
21. Sjögren's syndrome in patients with newly diagnosed untreated non-Hodgkin's lymphoma.
Andonopoulos AP; Tiniakou M; Melachrinou M; Sfountouris H; Bounas A; Zervas C; Zoumbos NC
Rev Rhum Engl Ed; 1997 May; 64(5):287-92. PubMed ID: 9190001
[TBL] [Abstract][Full Text] [Related]
22. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
[TBL] [Abstract][Full Text] [Related]
23. Risk of malignancy in Korean patients with primary Sjögren's syndrome.
Kang J; Kim H; Kim J; Choi S; Jung SY; Jang EJ; Cho SK; Sung YK
Int J Rheum Dis; 2020 Aug; 23(9):1240-1247. PubMed ID: 32841507
[TBL] [Abstract][Full Text] [Related]
24. A clinical prediction rule for lymphoma development in primary Sjögren's syndrome.
Baldini C; Pepe P; Luciano N; Ferro F; Talarico R; Grossi S; Tavoni A; Bombardieri S
J Rheumatol; 2012 Apr; 39(4):804-8. PubMed ID: 22337248
[TBL] [Abstract][Full Text] [Related]
25. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome.
Theander E; Vasaitis L; Baecklund E; Nordmark G; Warfvinge G; Liedholm R; Brokstad K; Jonsson R; Jonsson MV
Ann Rheum Dis; 2011 Aug; 70(8):1363-8. PubMed ID: 21715359
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic role of CXCL13 biomarker in primary Sjogren's syndrome patients with parotid non-Hodgkin's lymphoma complication.
Badarinza M; Serban O; Maghear L; Pelea MA; Rosca RI; Fodor D; Stancu B
Med Clin (Barc); 2023 Jun; 160(11):484-488. PubMed ID: 37005121
[TBL] [Abstract][Full Text] [Related]
27. Raynaud's phenomenon in primary Sjögren's syndrome. Association with other extraglandular manifestations.
Kraus A; Caballero-Uribe C; Jakez J; Villa AR; Alarcón-Segovia D
J Rheumatol; 1992 Oct; 19(10):1572-4. PubMed ID: 1464870
[TBL] [Abstract][Full Text] [Related]
28. Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.
Quartuccio L; Isola M; Baldini C; Priori R; Bartoloni Bocci E; Carubbi F; Maset M; Gregoraci G; Della Mea V; Salvin S; De Marchi G; Luciano N; Colafrancesco S; Alunno A; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
J Autoimmun; 2014 Jun; 51():75-80. PubMed ID: 24231556
[TBL] [Abstract][Full Text] [Related]
29. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects.
Baimpa E; Dahabreh IJ; Voulgarelis M; Moutsopoulos HM
Medicine (Baltimore); 2009 Sep; 88(5):284-293. PubMed ID: 19745687
[TBL] [Abstract][Full Text] [Related]
30. Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjögren's syndrome.
Kapsogeorgou EK; Papageorgiou A; Protogerou AD; Voulgarelis M; Tzioufas AG
Ann Rheum Dis; 2018 Aug; 77(8):1200-1207. PubMed ID: 29779010
[TBL] [Abstract][Full Text] [Related]
31. Risk of non-Hodgkin's lymphoma in primary Sjögren's syndrome: a population-based study.
Johnsen SJ; Brun JG; Gøransson LG; Småstuen MC; Johannesen TB; Haldorsen K; Harboe E; Jonsson R; Meyer PA; Omdal R
Arthritis Care Res (Hoboken); 2013 May; 65(5):816-21. PubMed ID: 23139233
[TBL] [Abstract][Full Text] [Related]
32. Primary Sjögren's Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development.
Goules AV; Argyropoulou OD; Pezoulas VC; Chatzis L; Critselis E; Gandolfo S; Ferro F; Binutti M; Donati V; Zandonella Callegher S; Venetsanopoulou A; Zampeli E; Mavrommati M; Voulgari PV; Exarchos T; Mavragani CP; Baldini C; Skopouli FN; Fotiadis DI; De Vita S; Moutsopoulos HM; Tzioufas AG
Front Immunol; 2020; 11():594096. PubMed ID: 33193443
[TBL] [Abstract][Full Text] [Related]
33. Primary Sjögren's syndrome as a systemic disease: a study of participants enrolled in an international Sjögren's syndrome registry.
Malladi AS; Sack KE; Shiboski SC; Shiboski CH; Baer AN; Banushree R; Dong Y; Helin P; Kirkham BW; Li M; Sugai S; Umehara H; Vivino FB; Vollenweider CF; Zhang W; Zhao Y; Greenspan JS; Daniels TE; Criswell LA
Arthritis Care Res (Hoboken); 2012 Jun; 64(6):911-8. PubMed ID: 22238244
[TBL] [Abstract][Full Text] [Related]
34. Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjogren's syndrome in Taiwan.
Weng MY; Huang YT; Liu MF; Lu TH
Ann Rheum Dis; 2012 Apr; 71(4):524-7. PubMed ID: 22072014
[TBL] [Abstract][Full Text] [Related]
35. [Lymphoma of the thyroid in a patient with autoimmune thyroiditis and Sjögren's syndrome--case report].
Mazur-Roszak M; Litwiniuk M; Łacka K
Pol Merkur Lekarski; 2008 Aug; 25(146):155-7. PubMed ID: 18942337
[TBL] [Abstract][Full Text] [Related]
36. Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren's syndrome.
Solans-Laqué R; López-Hernandez A; Bosch-Gil JA; Palacios A; Campillo M; Vilardell-Tarres M
Semin Arthritis Rheum; 2011 Dec; 41(3):415-23. PubMed ID: 21665245
[TBL] [Abstract][Full Text] [Related]
37. Lymphoma in Sjogren's syndrome.
Pavlidis NA; Drosos AA; Papadimitriou C; Talal N; Moutsopoulos HM
Med Pediatr Oncol; 1992; 20(4):279-83. PubMed ID: 1608349
[TBL] [Abstract][Full Text] [Related]
38. The five major autoimmune diseases increase the risk of cancer: epidemiological data from a large-scale cohort study in China.
Zhou Z; Liu H; Yang Y; Zhou J; Zhao L; Chen H; Fei Y; Zhang W; Li M; Zhao Y; Zeng X; Zhang F; Yang H; Zhang X
Cancer Commun (Lond); 2022 May; 42(5):435-446. PubMed ID: 35357093
[TBL] [Abstract][Full Text] [Related]
39. [Prognosis of patients with primary Sjögren's syndrome].
Brito-Zerón P; Ramos-Casals M
Med Clin (Barc); 2008 Feb; 130(3):109-15. PubMed ID: 18261383
[TBL] [Abstract][Full Text] [Related]
40. A longitudinal cohort study of Finnish patients with primary Sjögren's syndrome: clinical, immunological, and epidemiological aspects.
Pertovaara M; Pukkala E; Laippala P; Miettinen A; Pasternack A
Ann Rheum Dis; 2001 May; 60(5):467-72. PubMed ID: 11302868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]